Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Prognostic Role of AI-Echo

Evaluation of Artificial Intelligence-Assisted Echocardiography (AI-echo) in the Early Diagnosis and Prognostic Stratification of Left Atrial Cardiomyopathy (LACM) in Patients With Acute Cardiac Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Left atrial cardiomyopathy (LACM) is frequently underdiagnosed but plays a key role in increasing the risk of atrial fibrillation (AF) and thromboembolic events. While atrial strain is a validated marker of LACM, its measurement with conventional echocardiography can be time-consuming and less feasible in acute settings. The use of AI-assisted echocardiography (AI-echo) may help streamline image acquisition and analysis, offering faster and potentially more accurate assessment. This study aims to compare the time required for atrial strain analysis using AI-echo versus standard methods. It also explores how changes in strain parameters (LASr, LASct, LAScd) relate to the onset of AF and in-hospital adverse outcomes, adjusting for comorbidities and conventional echo variables. Main endpoints include time reduction with AI-echo and the association between strain changes and AF, complications, or mortality during hospitalization.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Age between 18 and 85 years. 2. Hospitalization in CCU for acute cardiac pathology (e.g. acute coronary syndrome, acute or exacerbated heart failure, malignant arrhythmias, etc.). 3. Ability to provide written willing to sign a consent form. Who Should NOT Join This Trial: 1. Severe hemodynamic instability, history to contraindicate the execution of the echocardiographic examination. 2. Severely inadequate echocardiographic window that precludes atrial or ventricular morpho-functional assessment. 3. Inability to continue the study for clinical reasons, logistics or patient refusal. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Age between 18 and 85 years. 2. Hospitalization in CCU for acute cardiac pathology (e.g. acute coronary syndrome, acute or exacerbated heart failure, malignant arrhythmias, etc.). 3. Ability to provide written informed consent. Exclusion Criteria: 1. Severe hemodynamic instability, history to contraindicate the execution of the echocardiographic examination. 2. Severely inadequate echocardiographic window that precludes atrial or ventricular morpho-functional assessment. 3. Inability to continue the study for clinical reasons, logistics or patient refusal.

Locations (1)

"Annunziata" Hospital
Cosenza, Italy